Annual Revenue
$80.21 M
-$20.17 M-20.09%
31 March 2024
Summary:
LakeShore Biopharma annual revenue is currently $80.21 million, with the most recent change of -$20.17 million (-20.09%) on 31 March 2024. During the last 3 years, it has risen by +$42.27 million (+111.43%). LSB annual revenue is now -20.09% below its all-time high of $100.37 million, reached on 31 March 2023.LSB Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$13.38 M
-$11.77 M-46.80%
30 September 2023
Summary:
LakeShore Biopharma quarterly revenue is currently $13.38 million, with the most recent change of -$11.77 million (-46.80%) on 30 September 2023. LSB quarterly revenue is now -56.96% below its all-time high of $31.08 million, reached on 01 June 2022.LSB Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$38.53 M
-$14.95 M-27.95%
30 September 2023
Summary:
LakeShore Biopharma TTM revenue is currently $38.53 million, with the most recent change of -$14.95 million (-27.95%) on 30 September 2023. LSB TTM revenue is now -35.15% below its all-time high of $59.41 million, reached on 01 September 2022.LSB TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LSB Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -20.1% | - | - |
| 3 y3 years | +111.4% | - | - |
| 5 y5 years | - | - | - |
LSB Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -20.1% | +111.4% | -57.0% | at low | -35.1% | +24.0% |
| 5 y | 5 years | -20.1% | +111.4% | -57.0% | at low | -35.1% | +24.0% |
| alltime | all time | -20.1% | +111.4% | -57.0% | at low | -35.1% | +24.0% |
LakeShore Biopharma Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | $80.21 M(-20.1%) | - | - |
| Sept 2023 | - | $13.38 M(-46.8%) | $38.53 M(-28.0%) |
| June 2023 | - | $25.15 M(-11.2%) | $53.48 M(-10.0%) |
| Mar 2023 | $100.37 M | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | $28.33 M(-8.9%) | $59.41 M(+91.1%) |
| June 2022 | - | $31.08 M | $31.08 M |
| Mar 2022 | $78.30 M(+106.4%) | - | - |
| Mar 2021 | $37.93 M | - | - |
FAQ
- What is LakeShore Biopharma annual revenue?
- What is the all time high annual revenue for LakeShore Biopharma?
- What is LakeShore Biopharma annual revenue year-on-year change?
- What is LakeShore Biopharma quarterly revenue?
- What is the all time high quarterly revenue for LakeShore Biopharma?
- What is LakeShore Biopharma TTM revenue?
- What is the all time high TTM revenue for LakeShore Biopharma?
What is LakeShore Biopharma annual revenue?
The current annual revenue of LSB is $80.21 M
What is the all time high annual revenue for LakeShore Biopharma?
LakeShore Biopharma all-time high annual revenue is $100.37 M
What is LakeShore Biopharma annual revenue year-on-year change?
Over the past year, LSB annual revenue has changed by -$20.17 M (-20.09%)
What is LakeShore Biopharma quarterly revenue?
The current quarterly revenue of LSB is $13.38 M
What is the all time high quarterly revenue for LakeShore Biopharma?
LakeShore Biopharma all-time high quarterly revenue is $31.08 M
What is LakeShore Biopharma TTM revenue?
The current TTM revenue of LSB is $38.53 M
What is the all time high TTM revenue for LakeShore Biopharma?
LakeShore Biopharma all-time high TTM revenue is $59.41 M